Thursday's Winners & Losers: Intel
Shares of Intel (INTC) were up $1.13, or 4.7%, to $24.97 after an analyst at Lehman Brothers raised his price target on the stock to $26 from $24 on the belief that demand for the company's products remain strong. Tim Luke, an analyst at Lehman, reiterated his overweight rating on the stock.
Asia Time (TYM), a distributor of watch-movement components based, jumped to new highs. The Hong Kong-based company reported first-quarter earnings of $2.4 million, or 8 cents a share, vs. $193,000, or a penny a share, a year ago. Revenue increased 74% year over year to $36.8 million. Shares climbed 30.5% to $6.50.
Digital video recorder maker TiVo (TIVO) was up 57 cents, or 6.9%, to $8.83 after an analyst at Friedman Billings upgraded the stock to market perform from underperform. TiVo may accept a settlement in its long standing dispute with rival Dish Network (DISH), said the analyst.
Incyte (INCY) shares climbed 2.4% to $10.48 (on lower-than-average volume) after Piper Jaffray analyst Thomas Wei and Bank of America Securities analyst Katherine Kim reaffirmed buy ratings with $19 and $15 price targets, respectively. They expecting the company to present positive data at the American College of Rheumatology meeting in June.
On the losing side, Yucheng Technologies (YTEC), which provides information technology solutions and services for banking, fell 27% to $13.49. The Beijing company reported that first-quarter earnings improved 88% year over year to $1.4 million, or 8 cents a share. The Street had forecast EPS of 12 cents. Shares of Geron (GERN) recovered a bit a day after the Food and Drug Administration put a clinical hold on the biopharmaceutical company's GRNPPC1, a cell therapy for spinal cord injuries. Geron said the agency verbally notified it and that it will have more information when it receives an official letter regarding the hold. After losing 20% on Wednesday, shares added 1.5% to $4 Thursday.Select the service that is right for you!
COMPARE ALL SERVICESAction Alerts PLUS
TRY IT FREEJim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
Product Features:
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Dividend Stock Advisor
TRY IT FREENew! $49.95/yr
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
Product Features:
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Stocks Under $10
TRY IT FREEDavid Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.
Product Features:
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts
- Weekly roundups
Real Money
TRY IT FREE24/7 market commentary from Jim Cramer and 20+ veteran Wall Street gurus. Get access to the latest trading ideas on stocks, options, and ETFs as well as a real-time forum to see the pros exchanging their investment ideas.
Product Features:
- Jim Cramer + 20 Wall Street pros
- Intraday commentary & news
- Real-time trading forum
- Actionable trade ideas
Real Money Pro
TRY IT FREEAll of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
Product Features:
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Options Profits
TRY IT FREEOur options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
Product Features:
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV